Chandel SS, Shirsat M, Sahu RK, Nayak SS

Language: English
References: 35
Page: 482-489
PDF size: 293.88 Kb.

ABSTRACT

Introduction and aim. Aegle marmelos is an important traditional herbal medicine used in India. The dietary inclusion of the plant has never exposed earlier for its hepatoprotective activity. This study aimed to investigate the modulator efficacy of dietary inclusion of Aegle marmelos against Cisplatin - induced hepatotoxicity in Wistar albino rats. Material and methods. Animals were divided into five different groups; Group I was given basal diets only, Group II was fed basal diets with Aegle marmelos in 4% concentration, while Group III was fed basal diets co-administered with Cisplatin. Group IV and V were administered diets containing 2% and 4% Aegle marmelos respectively, for 27 days prior to Cisplatin administration. Cisplatin was administered to the rats for 3 days leads to a reduction in the activities of the antioxidant enzymes like lipid peroxidation (LPO) and endogenous antioxidant systems such as reduced superoxide dismutase (SOD), glutathione (GSH) and catalase in liver homogenate caused to produce the impairment of hepatic functions. Results. The administration of fruit part of Aegle marmelos to Wistar rats showed a significant fall in the elevated Lipid peroxidation, superoxide dismutase, glutathione and catalase concentration, moreover, it diminished the increased serum level of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), acid phosphatase (ACP) and bilirubin. Conclusions. We can conclude that the hepatoprotective activity of Aegle marmelos was due to its antioxidant effect as evidenced by increasing activity of antioxidant enzymes with enhanced hepatic function and significantly changed the physiological parameters.

REFERENCES

1. Ciarimboli G, Ludwig T, Lang D, Pavenstadt H, Koepsell H, Piechota HJ, Haier J, et al. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 2005; 167: 1477-84.

2. Lu Y, Cederbaum AI. Cisplatin-Induced Hepatotoxicity Is Enhanced by Elevated Expression of Cytochrome P450 2E1. Toxicol Sci 2006; 89: 515-23.

3. Negishi K, Noiri E, Sugaya T, Li S, Megyesi J, Nagothu K, Portilla D. A role of liver fatty acid-binding protein in cisplatininduced acute renal failure. Kidney International 2007; 72: 348-58.

4. Yu Y-N, Chen H, Li Y. Effect of Bicyclol on Cisplatin-Induced Hepatotoxicity in the Hepatocarcinoma 22 Tumour-Bearing Mice. Basic & Clinical Pharmacology & Toxicology 2009; 104: 300-5.

5. Hogle WP. Cytoprotective agents used in the treatment of patients with cancer. Semin Oncol Nurs 2007; 23: 213-24.

6. Kaloyanides GJ. Metabolic interactions between drugs and renal tubulo-interstitial cells: role in nephrotoxicity. Kidney International 1991; 39: 531-40.

7. Sweetman SC. Antineoplastic and immunosupressants. From Martindale: The Complete Drug Reference. Pharmaceutical Press, London, UK 2002; 33: 525-7.

8. Goldstein RS, Mayor GH. The nephrotoxicity of cisplatin. Life Science 1983; 32: 685-90.

9. Goto S, Yoshida K, Morikawa T, Urata Y, Suzuki K, Kondo T. Augmentation of transport for cisplatin-glutathione adducts in cisplatin resistant cancer-cells. Cancer Research 1995; 55: 4297-301.

10. Antonio Z, Cafaggi S, Mariggio MA, Vannozzi MO, Bocchini MV, Caviglioli G, Viale M. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. Eur J Pharmacol 2002; 442: 265-72.

11. Liu J, Liu Y, Habeebu SM, Klassen CD. Metallothionein (MT) - null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicology and Applied Pharmacology 1998; 149: 24-31.

12. Chen D, Milacic V, Frezza M, Dou QP. Metal complexes, their cellular targets and potential for cancer therapy. Current Pharmaceutical Design 2009; 15: 777-91.

13. Zhang J, Wang L, Xing Z, Liu D, Sun J, Li X, Zhang Y. Status of bi- and multi-nuclear platinum anticancer drug development. Anti-cancer Agents in Medicinal Chemistry 2010; 10: 272-82.

14. Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Critical Reviews in Oncology/Hematology 2002; 42: 317-25.

15. Brozovic A, Ambriovi?-Ristov A, Osmak M. The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Critical Reviews in Toxicology 2010; 40: 347-59.

16. Desoize B. Cancer and metals and metal compounds: Part I - Carcinogenesis. Critical Reviews in Oncology/Hematology 2002: 42: 1-3.

17. Shah N, Dizon DS. New-generation platinum agents for solid tumors. Future Oncology 2009; 5: 33-42.

18. Tsang RY, Al-Fayea T, Au HJ. Cisplatin overdose: toxicities and management. Drug Saf 2009; 32: 1109-22.

19. Sharma PC, Bhatia V. A review on Bael tree. Natural Product Radiance 2007; 6: 171-8.

20. Maity P, Hansda D, Bandopadhyay U, Mishra DK. Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.) Corr. Indian Journal of Experimental Biology 2009; 47: 849-61.

21. Rana BK, Singh UP, Taneja V. Antifungal activity and kinetics of inhibition by essential oil isolated from leaves of Aegle marmelos. J Ethnopharmacol 1997; 57: 29-34.

22. Lambole VB, Murti K, Kumar U, Bhatt SP, Gajera V. Phytopharmacological properties of Aegle marmelos as a potential medicinal tree: an overview. Int J Pharm Sci Rev Res 2010; 5: 67-71.

23. Yadav SS, Dahiya K, Gaine SA, Gulia SK. Antibacterial activity of Aegle marmelos (L) Correa. Int J Pharm Pharm Sci 2015; 7: 462-4.

24. Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol 2004; 48: 81-8.

25. Chandra D. Analgesic effect of aqueous and alcoholic extract of Madhuca Indica longifolia. Indian Journal of Pharmacology 2001; 33: 108-11.

26. Pawar RS, Bhutani KK. Madhucosides A and B, protobassic acid glycosides from Madhuca Indica with inhibitory activity on free radical release from phagocytes. J Nat Prod 2004; 67: 668-71.

27. Sharma R, Chandan G, Chahal A. Saini RV. Antioxidant and anticancer activity of methanolic extract from stephania elegans. Int J Pharm Pharm Sci 2017; 9: 245-9.

28. Singanan V, Singanan M, Begum H. The hepatoprotective effect of Bael leaves in alcohol induced liver injury in albino rats. IJST 2007; 2: 83-92.

29. Adedayo OA, Ganiyu O, Tosin RO, Oluwaseun JA. Modulatory effects of dietary inclusion of garlic (Allium sativum) on gentamycin-induced hepatotoxicity and oxidative stress in rats. Asian Pac J Trop Biomed 2013; 3: 470-5.

30. Ohkawa H, Onishi N, Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979; 95: 351-8.

31. Ellman GL. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959; 82: 70-7.

32. Kakkar P, Das B, Vishwanath PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochemistry & Biophysics 1984; 21: 130-2.

33. Woolson RF, Clarke WR. Statistical methods for the analysis of biochemical data. Wiley, New York. 2002; 2: 315-6.

34. Lee CK, Son SH, Park KK, Park JH, Lim SS, Chung WY. Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma. J Pharmacol Sci 2008; 106: 444-51.

35. Pratibha R, Sameer R, Rataboli PV, Bhiwgade DA, Dhume CY. Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats. Eur J Pharmacol 2006; 532: 290-3.